Scientist– Oligonucleotide Chemistry at Eli Lilly and Company

Boston, Massachusetts, United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

  • Bachelor's or Master's Degree in chemistry, biochemistry, pharmacology, or related scientific field
  • 1+ years of work experience in an academic laboratory, or preferably in an industrial setting
  • Demonstrated expertise in organic synthesis and advanced chromatographic purification techniques
  • Proven laboratory proficiency with analytical instruments such as HPLC and LC-MS
  • Strong research track record in synthetic organic chemistry/chemical biology/biotechnology
  • Analytically minded, systematic, and embrace data-driven decision making

Responsibilities

  • Design and execution of automated workflows for synthesizing, purifying, and analyzing ASOs, siRNAs, SSOs, and related oligonucleotides across various chemistries and scales using advanced instrumentation platforms
  • Perform synthesis and chromatographic purification of innovative phosphoramidite monomers, and carry out conjugation of novel ligands—such as small molecules and peptides—to oligonucleotides for targeted delivery
  • Apply analytical techniques including UV-Vis spectroscopy, NMR, HPLC, and LC-MS to evaluate both crude and purified synthetic compounds
  • Interpret and organize analytical data and research outcomes for presentation to project teams
  • Support resolution of technical issues and contribute scientific and technical insights to ongoing projects
  • Provide strategic input into experimental planning, integrated data analysis, and effective communication of results to scientific teams and leadership
  • Maintain meticulous records of experimental procedures and key steps to ensure reproducibility, including accurate documentation in electronic lab notebooks in accordance with Lilly’s quality standards
  • Assist with general lab operations such as ordering supplies, preparing reagents, and maintaining equipment
  • Collaborate closely with colleagues across multiple sub-teams within the Lilly LGM group
  • Adhere strictly to all health and safety protocols
  • Demonstrate a strong commitment to fostering a diverse and inclusive laboratory environment every day

Skills

Synthetic Organic Chemistry
Oligonucleotide Chemistry
Chemical Biology
Biotechnology
RNA Therapeutics
RNA Synthesis

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI